Literature DB >> 29340780

Health-related quality of life in outpatients with schizophrenia: factors that determine changes over time.

Cristina Domenech1,2, Carlo Altamura3, Corrado Bernasconi4, Ricardo Corral5, Helio Elkis6, Jonathan Evans7, Ashok Malla8, Marie-Odile Krebs9, Anna-Lena Nordstroem4, Mathias Zink10,11, Josep Maria Haro12,13.   

Abstract

PURPOSE: The objective of this study was to analyze the clinical factors associated with changes in HRQoL in outpatients with schizophrenia using both generic and condition-specific HRQoL scales.
METHODS: Adult outpatients with schizophrenia at least 18 years of age who did not have an acute psychotic exacerbation in the 3 months prior to baseline were recruited. PANSS dimensions were calculated based on Lindenmayer et al.'s five factors. HRQoL data were assessed by patients using the Schizophrenia Quality of Life Scale (SQLS), the Short Form-36 (SF-36), and the EuroQol-5 Dimension (EQ-5D) questionnaires.
RESULTS: Out of the 1345 patients included at baseline, 1196 (89%) were evaluated at 12 months. Regression models showed that the factor most consistently associated with HRQoL at endpoint was change in the PANSS negative symptoms score. A decrease in the PANSS negative symptoms score from baseline to 1 year was associated with a decrease in HRQoL during the same period. There were also significant associations of the change in PANSS excitatory factor with all the HRQoL scales except the SF-36 PCS. Female gender was associated with a decrease in all HRQoL ratings. There was also a relationship between years since onset and HRQoL. The longer the time since illness onset, the larger the decrease in HRQoL.
CONCLUSIONS: This study has found that, in outpatients with schizophrenia, changes in negative and excitement symptoms may have a greater an association with HRQoL than changes in positive, cognitive and depressive symptoms.

Entities:  

Keywords:  Community; Course; Health-related quality of life; Schizophrenia; Symptoms

Mesh:

Year:  2018        PMID: 29340780     DOI: 10.1007/s00127-018-1483-4

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  47 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice.

Authors:  Mirella Ruggeri; Michela Nosè; Chiara Bonetto; Doriana Cristofalo; Antonio Lasalvia; Giovanni Salvi; Benedetta Stefani; Francesca Malchiodi; Michele Tansella
Journal:  Br J Psychiatry       Date:  2005-08       Impact factor: 9.319

3.  An explanatory model of quality of life in schizophrenia: the role of processing speed and negative symptoms.

Authors:  Natalia Ojeda; Pedro Sánchez; Javier Peña; Edorta Elizagárate; Ana B Yoller; Miguel Gutiérrez-Fraile; Jesús Ezcurra; Olatz Napal
Journal:  Actas Esp Psiquiatr       Date:  2012-01-01       Impact factor: 1.196

4.  The influence of depressive symptoms on quality of life after stroke: a prospective study.

Authors:  Valeri Delgado Guajardo; Luisa Terroni; Matildes de Freitas Menezes Sobreiro; Maria Irene dos Santos Zerbini; Gisela Tinone; Milberto Scaff; Dan V Iosifescu; Mara Cristina Souza de Lucia; Renério Fráguas
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-11-12       Impact factor: 2.136

5.  Quality of life of individuals with schizophrenia living in the community: relationship to socio-demographic, clinical and psychosocial characteristics.

Authors:  Chiu-Yueh Hsiao; Ming-Hong Hsieh; Chiu-Jung Tseng; Shu-Hui Chien; Ching-Chi Chang
Journal:  J Clin Nurs       Date:  2012-08       Impact factor: 3.036

6.  Reliability and validity of the EuroQol in patients with osteoarthritis of the knee.

Authors:  M Fransen; J Edmonds
Journal:  Rheumatology (Oxford)       Date:  1999-09       Impact factor: 7.580

7.  [Study of Flexible Doses of Paliperidone ER in Pacients with Schizophrenia who Have Undergone Inefficient Treatment with other Antipsychotics].

Authors:  Rodrigo Córdoba; Juan Fernando Cano; César Augusto Arango-Dávila; Carlos Miranda; Jorge Holguín; Darío Fernández; Miguel Márquez; Christian Lupo; Pedro Gargoloff; Gustavo Petracca; César Lucchetti
Journal:  Rev Colomb Psiquiatr       Date:  2014-05-10

8.  The Argentine-Spanish SF-36 Health Survey was successfully validated for local outcome research.

Authors:  Federico A Augustovski; Gabriela Lewin; Ezequiel García-Elorrio; Adolfo Rubinstein
Journal:  J Clin Epidemiol       Date:  2008-09-10       Impact factor: 6.437

9.  Five factor model of schizophrenia: replication across samples.

Authors:  J P Lindenmayer; S Grochowski; R B Hyman
Journal:  Schizophr Res       Date:  1995-02       Impact factor: 4.939

10.  Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE).

Authors:  Frédéric Rouillon; Lars Eriksson; Benjaminas Burba; Jiri Raboch; Georgios Kaprinis; Andreas Schreiner
Journal:  Acta Neuropsychiatr       Date:  2013-10       Impact factor: 3.403

View more
  3 in total

1.  Predictors of Functioning and Recovery Among Men and Women Veterans with Schizophrenia.

Authors:  Nichole Goodsmith; Amy N Cohen; Eric R Pedersen; Elizabeth Evans; Alexander S Young; Alison B Hamilton
Journal:  Community Ment Health J       Date:  2022-05-28

2.  Application of functional analytic psychotherapy to manage schizophrenia.

Authors:  Usri Sengupta; Amool Ranjan Singh
Journal:  Ind Psychiatry J       Date:  2021-06-04

3.  Phenome-wide and genome-wide analyses of quality of life in schizophrenia.

Authors:  Raha Pazoki; Bochao Danae Lin; Kristel R van Eijk; Dick Schijven; Sonja de Zwarte; Sinan Guloksuz; Jurjen J Luykx
Journal:  BJPsych Open       Date:  2020-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.